Core Insights - NVIDIA Corporation has become the world's most valuable company with a market capitalization of approximately $4.5 trillion, a significant increase from around $0.5 billion at its IPO [1] - NVIDIA's shares have surged 427,191.5% since inception, driven by the demand for its GPUs, which are essential for AI training and data centers [2] - Micron Technology and Palantir Technologies have also seen substantial gains, with stock increases of 405.9% and 412.6% respectively, outpacing NVIDIA's growth of 153% over the past two years [3] NVIDIA - NVIDIA's growth is primarily attributed to its GPUs becoming the backbone of AI technology, particularly with the demand for chips based on its Blackwell architecture [2] - The company has experienced strong quarter-over-quarter growth in sales and profits due to relentless demand for its products [2] Micron Technology - Micron has gained attention due to the rising demand for its high-bandwidth memory (HBM) chips, driven by AI expansion [5] - The company expects fiscal Q2 2026 revenues to be between $18.3 billion and $19.1 billion, an increase from $13.64 billion in Q1 2026 [6] - Micron's expected earnings growth rate for the current year is 300.7%, supported by sustained demand for HBM chips despite supply constraints [7] Palantir Technologies - Palantir is experiencing growth due to its competitive edge and the popularity of its Artificial Intelligence Platform (AIP), which has seen robust demand among U.S. commercial clients and government agencies [9][10] - The U.S. commercial segment revenues increased by 137% year over year, reaching $507 million in Q4 2025, while government revenues rose 66% year over year to $570 million [10] - Palantir anticipates full-year 2026 revenues to exceed $7.182 billion, more than doubling from $3.320 billion in 2025, supported by a remaining deal value of $4.38 billion [11]

If recent market action feels confusing, it should. Over the past several weeks, many of the market’s former leaders have been sharply repriced, in a trend that has been evolving for months. Mega-cap technology companies such as Microsoft ((MSFT) and Amazon ((AMZN), along with higher-beta growth names including Robinhood Markets ((HOOD), AppLovin ((APP), and Palantir Technologies ((PLTR) among many others, have fallen dramatically, in some cases as much as 50% from their 2025 highs. Yet despite the severity ...

Core Viewpoint - NVIDIA Corporation (NVDA) is currently positioned as a stronger investment compared to Super Micro Computer, Inc. (SMCI) due to its superior profitability metrics and robust demand for its AI chips, despite both companies benefiting from the AI infrastructure boom [1][12]. Group 1: NVIDIA's Performance - NVIDIA's revenues surged 62% year over year and 22% sequentially to $57 billion in the fiscal third quarter of 2026, with expectations for the fiscal fourth quarter to reach nearly $65 billion, plus or minus 2% [2][8]. - The company's gross margin increased to 73.4% in fiscal third-quarter 2026 from 72.4% in the previous quarter, indicating strong profitability [6][8]. - NVIDIA's return on equity (ROE) stands at an impressive 99.2%, showcasing its effective management and profitability compared to competitors [7][8]. Group 2: Supermicro's Performance - Supermicro's fiscal second-quarter 2026 sales climbed 123% year over year to $12.7 billion, significantly exceeding analysts' expectations of $10.4 billion [3][4]. - However, Supermicro's gross margins fell to 6.3% in fiscal second-quarter 2026 from 11.8% in the same quarter last year, indicating challenges in profitability [6][10]. - The company has a debt-to-equity ratio of 66.9%, which is considerably higher than NVIDIA's 6.3%, suggesting greater financial risk [10]. Group 3: Market Dynamics - The thawing trade tensions between the United States and China are expected to support NVIDIA's sales, as the U.S. government has approved the shipment of NVIDIA's H200 AI chips to China [2]. - Supermicro is scaling its AI server and storage capabilities, with its Data Center Building Block Solutions (DCBBS) gaining traction among AI clients [4][5].

Core Insights - Rivian Automotive reported a narrower loss of 54 cents per share in Q4 2025, compared to a loss of 69 cents estimated by Zacks Consensus, but wider than the previous year's loss of 52 cents [1] - Revenues for the quarter were $1.29 billion, exceeding the Zacks Consensus Estimate of $1.26 billion, but reflecting a year-over-year decline of 25.8% [1] Production and Deliveries - Total production for the quarter was 10,974 units, down from 12,727 units in the same quarter last year [2] - Total deliveries decreased to 9,745 units from 14,183 units a year ago [2] Financial Performance - Gross profit was $120 million, down from $170 million in the prior-year quarter, with a gross margin of 9% [3] - Adjusted operating expenses rose to $712 million from $620 million in the previous year [3] - Adjusted loss before interest, taxes, depreciation, and amortization was $465 million, compared to a loss of $277 million in Q4 2024 [3] Cash Flow and Expenditures - Net cash used by operating activities was $681 million, contrasting with net cash provided of $1.18 billion in the prior-year period [4] - Capital expenditures for Q4 were $463 million, up from $327 million a year ago [4] - Free cash outflow in the quarter was $1.14 billion [4] Segment Performance - The Automotive segment generated revenues of $839 million, a 45% year-over-year decline, primarily due to reduced regulatory credit sales and lower vehicle deliveries [5] - The Software and Services segment saw revenues of $447 million, more than doubling year-over-year, driven by new vehicle electrical architecture and software services [6] Financial Position - As of December 31, 2025, Rivian had cash and cash equivalents of $3.57 billion, down from $5.3 billion a year earlier [7] - Long-term debt remained relatively stable at $4.44 billion as of December 31, 2025, compared to $4.44 billion in the previous year [7] Future Guidance - For 2026, Rivian expects to deliver between 62,000 and 67,000 units, an increase from 42,284 in 2025 [8] - Adjusted EBITDA is projected to remain negative, ranging from $1.80 billion to $2.10 billion [8] - Anticipated capital expenditures for 2026 are between $1.95 billion and $2.05 billion [8]

Global Economic Outlook - The International Monetary Fund (IMF) projects global GDP growth of approximately 3.3% for 2026, supported by corporate investment in digital infrastructure and advanced technologies [1] - The U.S. labor market shows resilience, with nonfarm payrolls increasing by 130,000 in January 2026 and an unemployment rate of 4.3% [1] Industry Projections - The global semiconductor industry is expected to reach $975 billion in annual sales in 2026, driven by an AI infrastructure boom [2] - The Semiconductor Industry Association forecasts global semiconductor sales to approach $1 trillion in 2026, indicating a 26% growth, primarily due to advanced logic and high-bandwidth memory for generative AI workloads [5] Sector Performance - AI-linked infrastructure and healthcare innovation are expected to outperform the broader market in 2026, supported by strong demand drivers and favorable earnings momentum [3] - Hyperscalers like Microsoft, Amazon, and Alphabet are significantly investing in AI data centers and cloud infrastructure, which remains a core earnings catalyst [4] Aerospace and Defense - The industrial sector benefits from sustained defense spending, with U.S. national defense spending exceeding $800 billion annually, providing multi-year revenue visibility for prime contractors [8] - Companies like Lockheed Martin and RTX report substantial backlogs, with Lockheed Martin exiting 2025 with a $194 billion backlog and RTX with a $268 billion backlog, indicating extended revenue streams [9] Electrification and Grid Modernization - Electrification and grid modernization are identified as powerful structural drivers, with companies like Eaton and Siemens focusing on data center power demand and energy transition investments as key growth catalysts [10]

Core Insights - Valero Energy Corporation (VLO) stock is nearing its 52-week high of $206.77, closing at $196.91 on February 12, with a 50.3% increase compared to a 30.2% gain in the broader sub-industry [1][7] - Valero operates 15 refineries across the U.S., Canada, and Peru, with a combined throughput capacity of 3.2 million barrels per day, setting it apart from other independent refiners [2] - The current softness in crude oil prices is expected to benefit Valero by lowering input costs, as the West Texas Intermediate spot crude price is projected to drop from $65.40 per barrel in 2025 to $53.42 in 2026 [5] - Valero's refineries possess operational flexibility to process various feedstocks, allowing for adjustments in production based on market conditions, which enhances profitability [6] Financial Metrics - Valero's stock trades at a trailing 12-month EV/EBITDA of 7.73X, which is above the industry average of 5.06X [7][10] - Competitors Phillips 66 and HF Sinclair have trailing 12-month EV/EBITDA ratios of 13.03X and 6.82X, respectively [10] Market Position - The company is expected to benefit from strong refining margins due to lower crude prices, enabling it to convert cheaper feedstock into high-value products [9] - Despite the potential for profitability, Valero's current valuation suggests it may be overvalued, prompting a recommendation for investors to wait for a more favorable entry point [12]

Key Takeaways WAT beat Q4 estimates with EPS up 10.5% and sales rising 7% year over year. Pharma and Industrial sales rose 8%, while Europe revenues climbed 13% reported.WAT guides 2026 EPS to $14.30-$14.50 on 5.5-7% constant currency sales growth.Waters Corporation (WAT) reported fourth-quarter 2025 non-GAAP earnings of $4.53 per share, which beat the Zacks Consensus Estimate by 0.67% and increased 10.5% year over year. Net sales of $932.4 million topped the Zacks Consensus Estimate by 0.55%. The figure in ...

Core Viewpoint - SiriusPoint (SPNT) is anticipated to show improvements in both revenue and earnings for the fourth quarter of 2025, with a revenue estimate of $776.1 million, reflecting a 26.6% year-over-year growth, and earnings expected at 54 cents per share, indicating a significant year-over-year growth of 515.4% [1][7]. Financial Performance - SiriusPoint has a history of exceeding earnings expectations, having beaten the Zacks Consensus Estimates in three quarters of 2025, with an average surprise of 49.16% [2]. - The Earnings ESP for SPNT stands at 0.00%, as both the Most Accurate Estimate and the Zacks Consensus Estimate are at 54 cents per share [4]. Factors Influencing Q4 Results - The fourth-quarter results are likely to benefit from improved performance in both the Insurance & Services and Reinsurance segments, with premium growth driven by the expansion of Surety and growth in Accident & Health (A&H) lines [5][6]. - An increase in expenses is expected due to loss and loss adjustment expenses, but prudent underwriting and a less active catastrophe environment may improve the combined ratio [6]. Stock Performance and Valuation - SPNT's stock has outperformed the industry, sector, and the S&P 500 in the fourth quarter of 2025 [10]. - The stock is currently trading at a price-to-book ratio of 1.2, which is lower than the industry average of 2.61 [11].

Core Viewpoint - Sanofi has announced a leadership change, appointing Belén Garijo as the new CEO effective April 29, 2026, following the decision not to renew the mandate of current CEO Paul Hudson, which has led to a 4.5% drop in shares on February 12, 2026 [1][7]. Leadership Change - Paul Hudson's last day as CEO will be February 17, 2026, and Olivier Charmeil will serve as interim CEO until Garijo takes over [2]. - Belén Garijo, a Spanish national, previously served as CEO of Merck KGaA and has held roles at Abbott Laboratories and Sanofi [2]. Market Reaction - Investors have reacted negatively to the sudden CEO change, expressing concerns over Garijo's lack of a proven track record in leading large companies [3]. Stock Performance - Over the past six months, Sanofi's shares have declined by 4.1%, contrasting with a 28.4% increase in the industry [4]. Company Challenges - Sanofi is recognized as a major vaccine manufacturer and has a significant immunology drug, Dupixent, expected to generate around €22 billion in sales by 2030 [5]. - The company has faced setbacks in its research and development (R&D) efforts and pipeline innovation, which may have contributed to the decision for a leadership change [8][9]. - Sanofi has lagged in mergers and acquisitions compared to peers, impacting its growth and diversification [9]. Future Focus - Garijo's primary objectives will include enhancing R&D productivity, governance, and innovation, with the potential to turn around the company's fortunes [10].

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, the task of finding cutting-edge growth stocks is made easy with the help of the Z ...